Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
H.R. 2075IntroducedHouse · nowSenatePresidentLawIn committee
Sec. 2 · H.R. 2075

No research involving human fetal tissue obtained pursuant to an induced abortion

Read this section in the full bill →

This section appears in one version only, so there is nothing to compare yet.

(a) In general (1) In general No Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion. (2) Development of new, ethical cell lines Subsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion. (3) Research involving human fetal tissue obtained after a miscarriage or stillbirth permitted Any research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act (42 U.S.C. 289g–1). (b) Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirth Section 498A of the Public Health Service Act (42 U.S.C. 289g–1) is amended— (1) in the section heading, by striking transplantation of fetal tissue and inserting human fetal tissue obtained after a miscarriage or stillbirth; (2) by amending subsection (a) to read as follows: (a) Establishment of program The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.; (3) in subsection (b)— (A) in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation; and (B) in paragraph (2)— (i) by striking subparagraph (A); and (ii) by redesignating subparagraphs (B) and (C) as (A) and (B), respectively; (4) in subsection (c)(1)(B), by striking pursuant to a spontaneous or induced abortion or pursuant to and inserting after a miscarriage or; and (5) by amending subsection (g) to read as follows: (g) Definitions In this section: (1) Human fetal tissue The term human fetal tissue means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth. (2) Miscarriage The term miscarriage means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks. (3) Stillbirth The term stillbirth means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more. (4) Unborn child The term unborn child has the meaning given such term in section 1841(d) of title 18, United States Code.. (c) Conforming repeal Section 113 of the National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 289g–1 note) is repealed.